vs
嘉德诺（BTSG）与泛美白银（PAAS）财务数据对比。点击上方公司名可切换其他公司
嘉德诺的季度营收约是泛美白银的1.3倍（$3.6B vs $2.8B）
嘉德诺是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品与医疗产品分销，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医用外科用品，还运营着规模位居前列的放射性药物网络。
泛美白银是一家总部位于加拿大的知名矿业企业，业务主要布局于拉丁美洲地区，目前在墨西哥、秘鲁、玻利维亚、阿根廷等国持有多座在产矿山，同时运营多个待开发矿业项目，是全球白银矿业领域的重要参与者。
BTSG vs PAAS — 直观对比
营收规模更大
BTSG
是对方的1.3倍
$2.8B
损益表 — Q4 FY2025 vs Q3 FY2022
| 指标 | | |
|---|---|---|
| 营收 | $3.6B | $2.8B |
| 净利润 | $77.1M | — |
| 毛利率 | 11.6% | 27.0% |
| 营业利润率 | 3.0% | — |
| 净利率 | 2.2% | — |
| 营收同比 | 16.3% | — |
| 净利润同比 | 381.8% | — |
| 每股收益（稀释后） | $0.34 | $-1.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BTSGPAAS
| Q4 25 | $3.6B | — | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $2.9B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.6B | — |
净利润BTSGPAAS
| Q4 25 | $77.1M | — | ||
| Q3 25 | $55.8M | — | ||
| Q2 25 | $28.2M | — | ||
| Q1 25 | $29.5M | — | ||
| Q4 24 | $16.0M | — | ||
| Q3 24 | $-8.2M | — | ||
| Q2 24 | $19.9M | — | ||
| Q1 24 | $-45.8M | — |
毛利率BTSGPAAS
| Q4 25 | 11.6% | — | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 11.9% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 14.0% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | 14.3% | — |
营业利润率BTSGPAAS
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 0.3% | — |
净利率BTSGPAAS
| Q4 25 | 2.2% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | -1.8% | — |
每股收益（稀释后）BTSGPAAS
| Q4 25 | $0.34 | — | ||
| Q3 25 | $0.26 | — | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $0.11 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $-0.26 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.4M | — |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | — |
| 总资产 | $6.4B | — |
| 负债/权益比越低杠杆越低 | 1.34× | — |
8季度趋势，按日历期对齐
现金及短期投资BTSGPAAS
| Q4 25 | $88.4M | — | ||
| Q3 25 | $140.3M | — | ||
| Q2 25 | $70.1M | — | ||
| Q1 25 | $52.3M | — | ||
| Q4 24 | $61.3M | — | ||
| Q3 24 | $36.0M | — | ||
| Q2 24 | $25.0M | — | ||
| Q1 24 | $58.0M | — |
总债务BTSGPAAS
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.6B | — |
股东权益BTSGPAAS
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
总资产BTSGPAAS
| Q4 25 | $6.4B | — | ||
| Q3 25 | $6.0B | — | ||
| Q2 25 | $5.9B | — | ||
| Q1 25 | $5.8B | — | ||
| Q4 24 | $5.9B | — | ||
| Q3 24 | $5.8B | — | ||
| Q2 24 | $5.6B | — | ||
| Q1 24 | $5.7B | — |
负债/权益比BTSGPAAS
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.58× | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 1.64× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $231.6M | — |
| 自由现金流经营现金流 - 资本支出 | $193.9M | — |
| 自由现金流率自由现金流/营收 | 5.5% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 3.00× | — |
| 过去12个月自由现金流最近4个季度 | $394.7M | — |
8季度趋势，按日历期对齐
经营现金流BTSGPAAS
| Q4 25 | $231.6M | — | ||
| Q3 25 | $107.9M | — | ||
| Q2 25 | $49.1M | — | ||
| Q1 25 | $101.6M | — | ||
| Q4 24 | $90.6M | — | ||
| Q3 24 | $27.2M | — | ||
| Q2 24 | $-15.2M | — | ||
| Q1 24 | $-78.9M | — |
自由现金流BTSGPAAS
| Q4 25 | $193.9M | — | ||
| Q3 25 | $92.2M | — | ||
| Q2 25 | $24.7M | — | ||
| Q1 25 | $84.0M | — | ||
| Q4 24 | $75.3M | — | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $-39.0M | — | ||
| Q1 24 | $-100.7M | — |
自由现金流率BTSGPAAS
| Q4 25 | 5.5% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -3.9% | — |
资本支出强度BTSGPAAS
| Q4 25 | 1.1% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.8% | — |
现金转化率BTSGPAAS
| Q4 25 | 3.00× | — | ||
| Q3 25 | 1.93× | — | ||
| Q2 25 | 1.74× | — | ||
| Q1 25 | 3.44× | — | ||
| Q4 24 | 5.66× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.76× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
PAAS
暂无分部数据
